Dr V V Rao's Insider Trades & SAST Disclosures
Dr V V Rao's most recent trade in Laurus Labs Ltd. was a Acquisition of 2,600 Equity Shares done at an average price of Rs. 524.7 . Disclosure was reported to the exchange on June 3, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Dr V V Rao's has made SAST transactions in Bliss GVS Pharma Ltd. recently where a Acquisition of 3,000,000 shares done . Disclosure was reported to the exchange on March 31, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | Shruti Vishal Rao & Dr Vibha Gagan Sharma | Other | Acquisition | 04 Apr 2022 | 3,000,000 | - | 2.90% | - | 28 Mar 2022 28 Mar 2022 |
SAST (10(6)) | - | - | |
| Bliss GVS Pharma | Shruti V Rao & Dr Vibha G Sharma | Other | Acquisition | 04 Apr 2022 | 3,000,000 | - | 0% | - | 28 Mar 2022 28 Mar 2022 |
SAST (10(6)) | - | - | |
| Bliss GVS Pharma | Shruti Vishal Rao & Dr Vibha Sharma | Promoter | Acquisition | 28 Mar 2022 | 3,000,000 | - | 2.90% | - | 28 Mar 2022 28 Mar 2022 |
SAST (10(1)(a)) | - | None | |
| Bliss GVS Pharma | Shruti V Rao & Dr. Vibha G Sharma | Promoter | Acquisition | 24 Mar 2022 | 3,000,000 | - | 2.90% | - | 28 Mar 2022 28 Mar 2022 |
SAST (10(1)(a)) | - | None | |
| Laurus Labs | Dr. Venugopala Rao Malempati | Director | Acquisition | 03 Jun 2021 | 2,600 | 32,600 (0.01%) | 0.00% | 524.7 | 1,364,300 | 31 May 2021 02 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Laurus Labs | Dr. Lakshmana Rao C V | Promoter & Director | Revoke | 12 Mar 2021 | 800,000 | 13,850,145 (2.58%) | 0.15% | 365 | 292,000,000 | 12 Mar 2021 12 Mar 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Laurus Labs | Dr. Venugopala Rao Malempati | Director | Acquisition | 09 Feb 2021 | 1,300 | 30,000 (0%) | 0.00% | 356.2 | 463,073 | 08 Feb 2021 08 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Laurus Labs | Dr. Venugopala Rao Malempati | Director | Acquisition | 06 Feb 2021 | 1,200 | 28,700 (0%) | 0.00% | 344.9 | 413,868 | 05 Feb 2021 05 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Laurus Labs | Dr. Venugopala Rao Malempati | Director | Acquisition | 06 Feb 2021 | 7,500 | 27,500 (0%) | 0.00% | 341.2 | 2,558,700 | 03 Feb 2021 03 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.